Creative Planning’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,402
Closed -$40K 2160
2019
Q3
$40K Hold
13,402
﹤0.01% 1812
2019
Q2
$25K Sell
13,402
-27,475
-67% -$56.2K ﹤0.01% 1875
2019
Q1
$79K Hold
40,877
﹤0.01% 1737
2018
Q4
$61K Sell
40,877
-4,800
-11% -$9.6K ﹤0.01% 1689
2018
Q3
$108K Buy
45,677
+8,475
+23% +$18.3K ﹤0.01% 1780
2018
Q2
$101K Buy
37,202
+14,984
+67% +$43.4K ﹤0.01% 1771
2018
Q1
$66K Buy
22,218
+3,600
+19% +$11.8K ﹤0.01% 1799
2017
Q4
$60K Buy
18,618
+6,400
+52% +$55.9K ﹤0.01% 1789
2017
Q3
$187K Hold
12,218
﹤0.01% 1620
2017
Q2
$245K Buy
12,218
+9,751
+395% +$120K ﹤0.01% 1400
2017
Q1
$25K Buy
2,467
+1,800
+270% +$20K ﹤0.01% 2986
2016
Q4
$6K Sell
667
-833
-56% -$8.94K ﹤0.01% 3894
2016
Q3
$16K Hold
1,500
﹤0.01% 3223
2016
Q2
$26K Buy
1,500
+800
+114% +$24.9K ﹤0.01% 2614
2016
Q1
$26K Buy
700
+67
+11% +$2.67K ﹤0.01% 2587
2015
Q4
$43K Buy
633
+33
+6% +$2.37K ﹤0.01% 2242
2015
Q3
$35K Buy
+600
New +$53.1K ﹤0.01% 2321
2015
Q2
Sell
-200
Closed -$14K 3504
2015
Q1
$14K Buy
+200
New +$12.9K ﹤0.01% 3003
2014
Q4
Sell
-67
Closed -$3K 4428
2014
Q3
$3K Sell
67
-71
-51% -$3.33K ﹤0.01% 3571
2014
Q2
$8K Hold
138
﹤0.01% 3010
2014
Q1
$11K Hold
138
﹤0.01% 2730
2013
Q4
$8K Hold
138
﹤0.01% 2680
2013
Q3
$9K Hold
138
﹤0.01% 2521
2013
Q2
$13K Buy
+138
New +$11.4K ﹤0.01% 2161

Creative Planning's FCSC Position: Q4 2019 in Review

Creative Planning sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 13,402 shares — an estimated $40K sold.

Creative Planning first reported a position in FCSC in Q2 2013 and held it in 24 quarters. The position peaked at $245K in Q2 2017. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.

  • Creative Planning reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
  • Creative Planning sold 13,402 Fibrocell Science Inc. shares in Q4 2019, an estimated $40K.
  • Creative Planning first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 24 quarters.
  • Creative Planning's Fibrocell Science Inc. position peaked at $245K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.

Based on Creative Planning's 13F filing for Q4 2019, filed 30 Jan 2020.